Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma
Authors:
- 20 August 2014
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 56 (4) , 1020-1026
Abstract
We evaluated the clinical outcomes and relapse patterns of 80 patients with primary sinonasal tract diffuse large B-cell lymphoma (SN-DLBCL) treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) chemotherapy at 22 institutions. A total of 59 (73.8%) patients received R-CHOP chemotherapy alone, whereas 21 (26.3%) were treated with R-CHOP followed by involved field radiotherapy (IFRT). In 73 patients with Ann Arbor stage I–II disease, no significant difference was found in the response rate or overall survival (OS) between R-CHOP alone (n = 52) and R-CHOP followed by IFRT (n = 21). Among 11 relapsed patients in this study, the most common pattern of relapse was local (n = 8, 11.8%), whereas central nervous system (CNS) relapse was observed in only one (1.9%) patient. These results suggest that patients with primary SN-DLBCL treated with R-CHOP have a relatively low CNS relapse rate and better OS compared to previous studies before the introduction of R.Keywords
This publication has 39 references indexed in Scilit:
- WHO Classification of Malignant Lymphomas in Korea: Report of the Third Nationwide StudyThe Korean Journal of Pathology, 2011
- Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapyAnnals of Oncology, 2009
- CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)Blood, 2009
- Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experienceInternational Journal of Hematology, 2009
- Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxisLeukemia & Lymphoma, 2005
- Primary diffuse large B‐cell non‐Hodgkin lymphoma of the paranasal sinuses: a report of 14 casesBritish Journal of Haematology, 2005
- Clinical analysis of extranodal non-Hodgkin's lymphoma in the sinonasal tractEuropean Archives of Oto-Rhino-Laryngology, 2004
- CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?Annals of Oncology, 2001
- Non‐Hodgkin's Lymphoma of the Sinonasal TractThe Laryngoscope, 2000
- Sinonasal Malignant Lymphomas: A Distinct Clinicopathological CategoryAnnals of Otology, Rhinology & Laryngology, 1999